Nkarta (NKTX) Other Non-Current Liabilities (2019 - 2026)
Nkarta (NKTX) posted quarterly Other Non-Current Liabilities of $87000.0 for Q1 2026, little changed year-over-year from $87000.0 in Q1 2025, and little changed quarter-over-quarter from $87000.0 in Q4 2025.
Nkarta (NKTX) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Nkarta's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $87000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities changed 0.0% year-over-year to $87000.0; the TTM figure through Mar 2026 stood at $87000.0 (changed 0.0% YoY), while the FY2025 annual figure was $87000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $87000.0, roughly flat from $87000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $87000.0 in Q4 2024, with the low at $5000.0 in Q3 2022.
- The 4-year median for Other Non-Current Liabilities is $87000.0 (2024), against an average of $60666.7.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities plunged 91.07% in 2022, then changed 0.0% in 2025.
- Nkarta's Other Non-Current Liabilities stood at $5000.0 in 2022, then jumped by 1640.0% to $87000.0 in 2024, then changed by 0.0% to $87000.0 in 2025, then changed by 0.0% to $87000.0 in 2026.
- Business Quant data shows NKTX's Other Non-Current Liabilities at $87000.0 in Q1 2026, $87000.0 in Q4 2025, and $87000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 87,000.00 |
| Mar 31, 2026 | 87,000.00 |
| Dec 31, 2025 | 87,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 18,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Jun 30, 2021 | 65,000.00 |
| Mar 31, 2021 | 75,000.00 |
| Dec 31, 2020 | 82,000.00 |
| Sep 30, 2020 | 96,000.00 |
| Jun 30, 2020 | 119,963.00 |
| Dec 31, 2019 | 134,000.00 |